Literature DB >> 2300539

Model of disposition of drugs administered into the human nasal cavity.

I Gonda1, E Gipps.   

Abstract

A mathematical model was developed to describe the rate processes involved in the disposition of drugs placed in their delivery systems into the human nasal cavity. The model contains first-order parallel and sequential irreversible rate processes representing the convective drug and carrier transport by fluid flow, mucociliary clearance and peristalsis, drug release and absorption, and decomposition of the drug prior to its appearance in the systemic circulation. The numerical values of the parameters used are based on literature data from clearance studies of nonabsorbable markers deposited in the human nasal cavity, and data obtained under a variety of experimental conditions are consistent with the model. The effect of bioadhesive carriers is successfully simulated by reducing the mucociliary clearance rate constants for the transport from the posterior part of the nose into the gastrointestinal tract. The simulation shows that bioadhesion improves bioavailability and reduces the variability in absorption which might be caused by a variable pattern of deposition in the nose. Variable bioavailability could result from removal of the drug from the nasal cavity by sniffing, blowing, or wiping the nose, leading to different drug residence times in the nose. The model simulations further suggest that drug decomposition in the nose, while lowering bioavailability, also reduces variable absorption due to variable residence times of the drug in the nose.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2300539     DOI: 10.1023/a:1015891727080

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

Review 1.  Enzymatic barriers to peptide and protein absorption.

Authors:  V H Lee
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1988       Impact factor: 4.889

Review 2.  Intranasal drug delivery for systemic medications.

Authors:  Y W Chien; S F Chang
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1987       Impact factor: 4.889

3.  Drugs administered directly into the respiratory tract: modeling of the duration of effective drug levels.

Authors:  I Gonda
Journal:  J Pharm Sci       Date:  1988-04       Impact factor: 3.534

4.  Intranasal drug delivery by spray and drops.

Authors:  J G Hardy; S W Lee; C G Wilson
Journal:  J Pharm Pharmacol       Date:  1985-05       Impact factor: 3.765

5.  Nasal delivery of polypeptides I: nasal absorption of enkephalins in rats.

Authors:  K S Su; K M Campanale; L G Mendelsohn; G A Kerchner; C L Gries
Journal:  J Pharm Sci       Date:  1985-04       Impact factor: 3.534

6.  Effects of dose, pH, and osmolarity on nasal absorption of secretin in rats.

Authors:  T Ohwaki; H Ando; S Watanabe; Y Miyake
Journal:  J Pharm Sci       Date:  1985-05       Impact factor: 3.534

7.  Intranasal administration of peptides: nasal deposition, biological response, and absorption of desmopressin.

Authors:  A S Harris; I M Nilsson; Z G Wagner; U Alkner
Journal:  J Pharm Sci       Date:  1986-11       Impact factor: 3.534

8.  Effects of concentration and volume on nasal bioavailability and biological response to desmopressin.

Authors:  A S Harris; M Ohlin; S Lethagen; I M Nilsson
Journal:  J Pharm Sci       Date:  1988-04       Impact factor: 3.534

9.  Intranasal and oral cocaine kinetics.

Authors:  P Wilkinson; C Van Dyke; P Jatlow; P Barash; R Byck
Journal:  Clin Pharmacol Ther       Date:  1980-03       Impact factor: 6.875

10.  Mechanism of nasal absorption of drugs I: Physicochemical parameters influencing the rate of in situ nasal absorption of drugs in rats.

Authors:  C H Huang; R Kimura; R B Nassar; A Hussain
Journal:  J Pharm Sci       Date:  1985-06       Impact factor: 3.534

View more
  7 in total

1.  Validity of in vitro tests on aqueous spray pumps as surrogates for nasal deposition.

Authors:  Julie D Suman; Beth L Laube; Ta-Chun Lin; Guillaume Brouet; Richard Dalby
Journal:  Pharm Res       Date:  2002-01       Impact factor: 4.200

2.  Microparticles of polyvinyl alcohol for nasal delivery. I. Generation by spray-drying and spray-desolvation.

Authors:  T Y Ting; I Gonda; E M Gipps
Journal:  Pharm Res       Date:  1992-10       Impact factor: 4.200

Review 3.  The nasal mucociliary clearance: relevance to nasal drug delivery.

Authors:  N G Schipper; J C Verhoef; F W Merkus
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

4.  Current understanding of nasal morphology and physiology as a drug delivery target.

Authors:  Julie D Suman
Journal:  Drug Deliv Transl Res       Date:  2013-02       Impact factor: 4.617

5.  Linking Suspension Nasal Spray Drug Deposition Patterns to Pharmacokinetic Profiles: A Proof-of-Concept Study Using Computational Fluid Dynamics.

Authors:  Alex Rygg; Michael Hindle; P Worth Longest
Journal:  J Pharm Sci       Date:  2016-06       Impact factor: 3.534

6.  Intranasal Delivery of Topically-Acting Levofloxacin to Rats: a Proof-of-Concept Pharmacokinetic Study.

Authors:  Joana Sousa; Gilberto Alves; Ana Fortuna; Amílcar Falcão
Journal:  Pharm Res       Date:  2017-07-26       Impact factor: 4.200

7.  A Systematic Approach in the Development of the Morphologically-Directed Raman Spectroscopy Methodology for Characterizing Nasal Suspension Drug Products.

Authors:  Gonçalo Farias; Jagdeep Shur; Robert Price; Elizabeth Bielski; Bryan Newman
Journal:  AAPS J       Date:  2021-05-18       Impact factor: 4.009

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.